Alcohol, Signaling, and ECM Turnover

Authors

  • Devanshi Seth,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Nympha B. D’Souza El-Guindy,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Minoti Apte,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Montserrat Mari,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Steven Dooley,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Manuela Neuman,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Paul S. Haber,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Gopal C. Kundu,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Agus Darwanto,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Willem J. De Villiers,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • A. Vonlaufen,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Z. Xu,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • P. Phillips,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • S. Yang,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • D. Goldstein,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • R. M. Pirola,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • J. S. Wilson,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Anna Moles,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Anna Fernández,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Anna Colell,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Carmen García-Ruiz,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • José C. Fernández-Checa,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Christoph Meyer,

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author
  • Nadja M. Meindl-Beinker

    1. From the Drug Health Services & Centenary Institute (DS, PSH), Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Internal Medicine (NBDE-G, AD, WJV), University of Kentucky and Veterans Affairs Medical Center, Lexington, Kentucky; Pancreatic Research Group (MA, AV, ZX, PP, SY, DG, RMP, JSW), South Western Sydney Clinical School, Wallace Wurth Building, The University of New South Wales, Sydney, Australia; Liver Unit and CIBEK (MM, AM, AF, AC, CG-R, JCF-C), IMDiM, Hospital Clínic i Provincial, CIBEREHD, IDIBAPS, Instituto Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona, Spain; Molecular Alcohol Research in Gastroenterology (SD, CM, NMM-B), II. Medical Clinic, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany; In Vitro Drug Safety and Biotechnology and Department of Pharmacology (MN), Faculty of Medicine, University of Toronto, Ontario, Canada; and National Centre for Cell Science (GCK), Pune, Maharashtra, India.
    Search for more papers by this author

Reprint requests: Devanshi Seth, Drug Health Services & Centenary Institute, Royal Prince Alfred Hospital, Page 5 Missenden Road, Camperdown, NSW 2050, Australia; Fax: +61 2 95157980; E-mail: devanshi.seth@email.cs.nsw.gov.au

Abstract

Alcohol is recognized as a direct hepatotoxin, but the precise molecular pathways that are important for the initiation and progression of alcohol-induced tissue injury are not completely understood. The current understanding of alcohol toxicity to organs suggests that alcohol initiates injury by generation of oxidative and nonoxidative ethanol metabolites and via translocation of gut-derived endotoxin. These processes lead to cellular injury and stimulation of the inflammatory responses mediated through a variety of molecules. With continuing alcohol abuse, the injury progresses through impairment of tissue regeneration and extracellular matrix (ECM) turnover, leading to fibrogenesis and cirrhosis. Several cell types are involved in this process, the predominant being stellate cells, macrophages, and parenchymal cells. In response to alcohol, growth factors and cytokines activate many signaling cascades that regulate fibrogenesis. This mini-review brings together research focusing on the underlying mechanisms of alcohol-mediated injury in a number of organs. It highlights the various processes and molecules that are likely involved in inflammation, immune modulation, susceptibility to infection, ECM turnover and fibrogenesis in the liver, pancreas, and lung triggered by alcohol abuse.

Ancillary